Richard Lifton, M.D., Ph.D.
Richard Lifton is Chairman and Sterling Professor of Genetics at Yale University, and Investigator of the Howard Hughes Medical Institute. He also directs the Yale Center for Human Genetics and Genomics. He received his B.A. from Dartmouth, M.D. and Ph.D. degrees from Stanford, and trained in medicine at Brigham and Women’s Hospital and Harvard prior to moving to Yale in 1993.
Dr. Lifton’s laboratory has used human genetics and genomics to identify causes of heart, kidney, and bone disease. By investigating thousands of families from around the world, his group has identified more than 25 human disease genes. These include key genes and pathways that are critical to the risk of heart attack, hypertension, osteoporosis, and stroke. These studies have provided new diagnostic and therapeutic approaches to these diseases, which affect more than one billion people worldwide.
Dr. Lifton also chairs the Scientific Advisory Board of Merck, the Medical Physiology Section of the National Academy of Sciences, and the NIH Advisory Committee for Large Scale Genomic Sequencing. He serves on the Council of the Institute of Medicine, the Scientific Advisory Boards of The Simons Foundation Autism Project, and The Gallo Foundation of the University of California, San Francisco.
His honors include election to the National Academy of Sciences and the Institute of Medicine as well as the highest scientific awards of the American Heart Association, the International Society of Hypertension, and the International Society of Nephrology; he is also the recipient of the 2008 Wiley Prize in Biomedical Sciences.
Dr. Richard Lifton received a B.A. from Dartmouth College and an M.D. and Ph.D. from Stanford University.